Team

 

 

 

Management Team

 

Will Martinez

CEO & CTO

Will is the founder of Nanotech Biomachines, Inc. He is a hands-on CEO, who enjoys building an experienced team to create innovative solutions for customers. His industrial R&D, manufacturing, and commercialization experience expands for over 8 years. He has extensive expertise in the manufacturing of nanomaterials and microsystems such as biosensors, MEMS, RF analog devices, and drug delivery devices. Will is in charge of interacting with customers and bridging their needs with innovative graphene products and solutions.

 

As CTO, Will oversees critical R&D and product development milestones for future company products. He has previously served in dynamic R&D teams at GE Global Research and Innovative Micro Technology (IMT) were he held research and engineering positions. Will holds multiple US patents in advanced materials and micro-devices. He earned his B.Sc. degree in Metallurgical & Materials Engineering from Colorado School of Mines, and his Masters degree in Materials Engineering from the University of California, Santa Barbara, in 2005. Will was born and raised in the southern Andes of Peru. When he is not working on creating solutions for customers or growing the company, he can be found cycling or running in the beautiful hills of Berkeley with his wife.

Scott Osterman

COO & VP of Sales

Scott has over 20 years of executive experience in leading international sales, marketing, operations, business and product development for Fortune 500, mid-market and venture-backed technology private and public enterprises. He has held positions of Chief Executive, General Manager and Vice President for technology companies. Scott is directly responsible of expanding the customer base and ensuring products excel customer needs and expectations.

 

Scott’s core experience includes strategic planning, turnaround, investor, board and media relations, M&A activities, fundraising, and strategic alliances. Scott has achieved aggressive double and triple digit growth targets and sales well beyond the $100M level. Previous companies include IKON Corporation and Amerimade Technologies. Scott manages daily manufacturing and sales operations, and interfaces directly with customers to optimize solutions. Scott holds a B.A. degree in Anthropology from the University of Montana. He was born and raised in beautiful Montana.

Mark Bagby

CFO

Mark is a veteran in corporate finance; he has over 21 years of experience in management, finance, accounting & controlling, business development, taxation, and legal affairs. As CFO of Nanotech Biomachines, inc., Mark is directly responsible for daily accounting, controlling, corporate finance, taxation, human resources, and budget management.

 

Mark works with the core management team to plan and execute on financial targets as well as maintain the financial structure of the company. Mark’s extensive experience provides a strong foundation for managing growth, financing of fixed assets, and scaling up operations. Previous positions include CFO and COO in fast growing technology startups in Silicon Valley. Mark’s core focus for the past two decades has been working with high tech startups to build their corporate finance and accounting structure. Previous employers/clients include Simplex Solutions, Cyberonix, Netflix, Skyfire Labs, and Meebo. He earned his M.A. in Economics from Tulane University in 1985 and his M.B.A. from Santa Clara University in 1991. Mark is a native of California.

Frank Robinson

VP of Product Development (Acting)

Frank’s experience in product, market, and business development expands for over 23 years. He has contributed to the development of 200+ products in 50 business and consumer markets in software, scientific instruments, semiconductor devices, and financial services. Frank is a pioneer of the sale-design-build process. Frank serves as the VP of Product Development (acting); he supports the management team on analyzing customer feedback, identifying market opportunities, and guiding product development.

 

Previous companies that have benefited from Frank’s methods and expertise include Applied Biosystems, KLA Tencor, Beckman Coulter, Citrix Systems, and Financial Engines to name a few. Frank’s expertise is critical to execute synchronous product and market development. Frank’s works with the management team to evaluate the business case of individual products, reduce market risk, and channel customer input for product development. Frank has a BA in Physics and a MBA in Finance from SUNY Buffalo. He is a native of Hornell, New York.

Back to Top >>

 

Scientific Advisors

 

Joe Gray, Ph.D.

Scientific Adviser, Life Science Applications

Prof. Gray is the Gordon Moore Endowed Chair of Biomedical Engineering at Oregon Health Sciences University (OHSU). He is also the Director of the Oregon Center for Spatial System Biomedicine (OCSSB) and Associate Director for Translational Research at the Knight Cancer Institute at OHSU. He is Principal Investigator of the National Cancer Institute / Integrative Cancer Biology Program (ICBP) Center for Cancer Systems Biology aimed at understanding and modeling of RTK signaling. Joe is Co-leader of the Stand Up to Cancer program aimed at rapidly improving management of the major subtypes of human breast cancer. Prof. Gray is also PI of a DOD Innovator project aimed at improving early breast cancer detection. Dr. Gray’s core expertise is in molecular analysis technologies, identification of genomic aberrations that contribute to cancer pathophysiology, and the development of systems biology strategies for enhanced marker guided cancer therapy – especially for breast and ovarian cancer. As member of the Scientific Board of Advisors, Prof. Gray collaborates and advises on R&D projects aimed at utilizing NTB’s proprietary graphene technologies in life science applications. Prof. Gray’s work is described in more than 400 publications and in 70 US patents.

Ethan Minot, Ph.D.

Scientific Adviser, Biosensor Technology

Prof. Minot earned his Ph.D. in physics from Cornell University in 2004. He is the lead researcher in biophysics, nanoelectronics, carbon nanomaterials, and carbon based biosensors at Oregon State University (OSU). He is an Associate Professor in the Department of Physics and he is Director of the Nanoelectronics Lab. Prof. Minot joined the Scientific Advisory Board (SAB) of Nanotech Biomachines, Inc. to collaborate and provide scientific advice on matters regarding nanoelectronic detection, optimization of signal-to-noise ratio, and surface functionalization of carbon-based sensor technology. He is a recipient of multiple awards including the NSF Career Award in 2012 and the HFSP Young Investigator Award in 2010.

Rodney Ruoff, Ph.D.

Scientific Adviser, Graphene Technology

Prof. Ruoff earned his Ph.D. in chemical physics from the University of Illinois at Urbana-Champaign in 1988. He joined the faculty of The University of Texas at Austin in September 2007. Within his broad range of research interests, Ruoff is recognized as a leader in understanding the mechanical, chemical, and physical properties of carbon structures such as carbon nanotubes and graphene sheets. His recent focus includes developing “graphene-based materials.” Graphene sheets can be added as a filler to strengthen composites such as polymer, ceramic, or metal composites. His research team has succeeded in creating transparent, but electrically conductive thin films using graphene. His team has used graphene to make ultracapacitors; and it is studying graphene for applications in thermal management and a variety of other applications. Prof. Ruoff joined the Scientific Advisory Board of the company in 2013.

Back to Top >>

 

Business Advisors

 

 

Raul Deju, Ph.D.

Sr. Business Advisor, and Director of JFK Entrepreneurial Leadership Program
Former CEO of URS, Chemical Waste Management, and Energy Solutions.

Dr Deju started his professional career with Gulf Oil Co, principally involved with its uranium mining subsidiary and later on at the US Department of Energy’s Hanford Site. He has taken on top execute positions and grown businesses to achieve multi-billion dollars in revenue. Key examples in the tech sector include URS Corporation, Chemical Waste Management, and Energy Solutions. Dr. Deju advises Nanotech Biomachines, Inc. on corporate team development, corporate management, sales growth, and market development strategies.

 

Dr. Deju has served in advisory committee roles with the US Secretary of Commerce and the US EPA Administrator. He has served on the faculty of the University of California, the University of Pittsburgh, St Mary’s College and JF Kennedy University’s MBA Program and served as Chair of the Bi-national US-Mexico Environmental Committee during the North American Free Trade Agreement’s formative process. Dr. Deju was recognized as one of the 25 Most Influential Latinos in the San Francisco Bay Area and has received Congressional, State and City of San Francisco recognitions. Dr. Deju received both his BS and his PhD from the New Mexico Institute of Mining and Technology.

Yulun Wang, Ph.D.

Business Advisor, and CEO of Intouch Health

Dr. Wang launched his career at the intersection of healthcare and technology with the founding of Computer Motion and the invention of AESOP, the first FDA-cleared surgical robot. Under his leadership, Computer Motion went public in 1997 and later merged with Intuitive Surgical. Dr. Wang advises Nanotech Biomachines, Inc. on business strategy, customer interfacing, team development, and corporate management.

 

Dr. Wang has received multiple entrepreneurship and leadership awards, and he was elected to the prestigious ranks of the National Academy of Engineering in 2011. He is the author of over 50 scientific publications, and holds over 100 patents registered in his name. Dr. Wang is a member of the University of California, Santa Barbara’s Electrical and Computer Engineering and Mechanical Engineering Advisory Board, the Hoag Memorial Hospital Presbyterian Board of Directors, and the American Telemedicine Association (ATA) Board of Directors, where he also serves as an officer. Dr. Wang is the Chairman and CEO of Intouch Health, named one of the fastest growing biomedical companies in the US by INC Magazine.

Yulun Wang, Ph.D.

Business Advisor, and CEO of Intouch Health

Dr. Wang launched his career at the intersection of healthcare and technology with the founding of Computer Motion and the invention of AESOP, the first FDA-cleared surgical robot. Under his leadership, Computer Motion went public in 1997 and later merged with Intuitive Surgical. Dr. Wang advises Nanotech Biomachines, Inc. on business strategy, customer interfacing, team development, and corporate management.

 

Dr. Wang has received multiple entrepreneurship and leadership awards, and he was elected to the prestigious ranks of the National Academy of Engineering in 2011. He is the author of over 50 scientific publications, and holds over 100 patents registered in his name. Dr. Wang is a member of the University of California, Santa Barbara’s Electrical and Computer Engineering and Mechanical Engineering Advisory Board, the Hoag Memorial Hospital Presbyterian Board of Directors, and the American Telemedicine Association (ATA) Board of Directors, where he also serves as an officer. Dr. Wang is the Chairman and CEO of Intouch Health, named one of the fastest growing biomedical companies in the US by INC Magazine.

img_5

Back to Top >>